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The reversible phosphorylation of proteins, controlled by
protein kinases and protein phosphatases, is a critical mecha-
nism by which eukaryotic organisms regulate cellular signal
transduction pathways. There are two superfamilies of protein
serine/threonine speci¢c phosphatases, the PPP and PPM fam-
ilies, which speci¢cally dephosphorylate serine/threonine resi-
dues [1]. The PPP family is comprised of three subtypes of
phosphatases, PP1, PP2A and PP2B, which are distinguished
by their associated regulatory subunits to form a variety of
holoenzymes. These enzymes show considerable evolutionary
sequence conservation in their catalytic domains, and the de-
phosphorylation activity of the PPP family is independent of
divalent cations and can be inhibited by the protein inhibitors-
1 and -2 as well as the tumor promoter okadaic acid. In
contrast, PPM family members are monomeric enzymes and
are unrelated in sequence to the PPP family, and they include
type 2C protein phosphatases (PP2C) and the pyruvate dehy-
drogenase phosphate. Sequence analysis reveals that there are
11 conserved motifs in the members of the PP2C superfamily
[2]. In addition, the dephosphorylation activity of PP2C re-
quires metal cations, Mn2 or Mg2, but its activity is not
sensitive to the tumor promoter okadaic acid and other inhib-
itors of the PPP family [1]. In the budding yeast Saccharomy-
ces cerevisiae, six PP2C-like genes, Ptc1p, Ptc2p, Ptc3p, Ptc4,
Ptc5 and YCR079w, have been identi¢ed, and proteins en-
coded by the former ¢ve genes have been demonstrated to
be PP2C enzymes [3]. In Candida albicans, an important hu-
man yeast pathogen, little is known about PP2C enzymes. In
this report, we have identi¢ed and characterized the ¢rst PP2C
phosphatase (CaPTC7) from the human fungal pathogen,
C. albicans, representing a novel member of the PP2C super-
family.
To investigate the roles of PP2C phosphatases in the patho-
genesis of C. albicans, potential PP2C homologous sequences
from the C. albicans genomic database (http://www-sequen-
ce.stanford.edu/group/candida) were extensively searched with
the six known budding yeast PP2C-like genes as queries. As a
result, the six C. albicans homologs of the known budding
yeast PP2C-like genes were identi¢ed according to their se-
quence similarities (Jiang et al., unpublished). Interestingly,
the gene YHR76 was found to encode a protein of 365 amino
acids (YHR76p), sharing limited sequence identity with the
budding yeast Ptc1p (GenBank accession No.: AAA34920)
in the catalytic domain, particularly in the two regions from
N44 to K107 and from V210 to I248 where the sequence
identities reach 28% and 30%, respectively (Fig. 1A). The se-
quence alignment of YHR76p with Ptc1p, human PP2CL2
(GenBank accession No.: AAG02232) and rat PP2CN (Gen-
Bank accession No.: AAC97497) revealed that the 250 amino
acid segment of the YHR76p at the C-terminus contains the
two invariant amino acids (160D and 235G) and the 11 motifs
conserved in the catalytic domain of all members of the PP2C
subfamily [2] (Fig. 1A), suggesting the presence of a potential
PP2C catalytic domain in YHR76p. Therefore, we designated
YHR76 as CaPTC7, the seventh PP2C-like gene in C. albi-
cans.
To examine if CaPTC7p has phosphatase activity, the DNA
fragment containing the potential catalytic domain (from A40
to K365) of CaPTC7p was ampli¢ed by PCR from the ge-
nomic DNA of C. albicans strain SC5314. The sense primer
with a NdeI site is 5P-CCCCATATGGCAAGGTCCTTTG-
CATCC-3P, and the antisense primer with a XhoI site is 5P-
CCCCTCGAGCTATTTAACCTTTACCAACACAACC-3P.
The ampli¢ed fragment was cloned into the NdeI and XhoI
sites of the pET28c vector, resulting in an in-frame N-termi-
nally truncated and His-tagged CaPTC7p (His-vCaPTC7p).
The construct was con¢rmed by DNA sequencing. The induc-
tion and puri¢cation of the recombinant protein in Escheri-
chia coli was carried out as described in the ‘Current Protocols
in Molecular Biology’. The recombinant His-vCaPTC7p mi-
grated at 47 kDa in 12% SDS^PAGE (Fig. 1B, lanes 2 and 3),
and was puri¢ed to nearly a single protein band by immobi-
lizing it on Ni2-NTA agarose beads and eluting it from the
beads (Fig. 1B, lane 4). The size of His-vCaPTC7p in the gel
is bigger than the predicted molecular weight (38 kDa), sug-
gesting that the His-vCaPTC7p migrates aberrantly in SDS^
PAGE.
The phosphatase activity of the recombinant His-
vCaPTC7p was assayed using a serine/threonine phosphatase
assay system (Promega, Madison, WI, USA) according to the
manufacturer’s instructions. As shown in Fig. 1C, the dephos-
phorylation activity of His-vCaPTC7p on the peptide sub-
strate was dependent on the presence of the cation cofactor
Mg2 or Mn2. The maximal phosphatase activity of His-
vCaPTC7 was detected at the concentration of 5 mM Mn2
(Fig. 1C). In the presence of Mg2, the phosphatase His-
vCaPTC7p achieved its highest activity at a concentration
of 10 mM (Fig. 1C). However, the activity of the recombinant
phosphatase in this Mg2 concentration was still lower than
that detected in the presence of 10 mM Mn2 under the same
conditions (Fig. 1C), suggesting that Mn2 is a relatively more
potent cofactor than Mg2 for the recombinant His-
vCaPTC7p. The dephosphorylation activity of the recombi-
nant His-vCaPTC7p was completely blocked by the protein
serine/threonine inhibitor NaF at a concentration of 50 mM
(data not shown). However, the phosphatase activity of the
recombinant His-vCaPTC7p was neither sensitive to okadaic
acid, a PP1 and PP2A inhibitor, nor to orthovanadate, a
protein tyrosine phosphatase inhibitor (data not shown). Tak-
en together, these results indicate that the CaPTC7p possesses
all the characteristics of a typical PP2C phosphatase.
After searching the GenBank database, we have not ob-
served any signi¢cant sequence homology between CaPTC7p
and other known PP2C enzymes. However, CaPTC7p shows
25% and 50% sequence identity in the N-terminal 116-amino
acid region and the C-terminal PP2C catalytic domain, respec-
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tively, with YHR076wp, a potential budding yeast homolog
(GenBank accession No.: NP_011943). The N-terminal region
of CaPTC7p contains a potential mitochondrion-targeting sig-
nal and a transmembrane domain (Fig. 1A), suggesting that it
likely resides in the mitochondrion where it might be involved
in the regulation of metabolic pathways [4]. In addition, the
catalytic domain of CaPTC7p displays 35, 36, 33 and 33%
sequence identities with the CG15035 gene product of Droso-
phila melanogaster (GenBank accession No.: AAF47506), the
hypothetical protein W09D10.4 of Caenorhabditis elegans
Fig. 1. A: The alignment of CaPTC7p with Ptc1p, rat PP2Cc, and human PP2CL2. The two invariant amino acids, D and G, are indicated by
upward arrows and the 11 conserved motifs found in the PP2C superfamily [2] are marked above the sequences. Residues highly conserved
within PP2C members are shaded. The potential mitochondrion-targeting sequence of CaPTC7p is underlined, within which, the putative trans-
membrane domain (I7 to S24) is double underlined, and the putative cleavage site within the R-3 motif (ARDY|S63) for the mitochondrial pre-
sequence [4] is indicated with the downward arrowhead. B: SDS^PAGE analysis of recombinant His-vCaPTC7p. Lanes 1^3: Total bacterial ly-
sates prepared from the cells expressing the His-vCaPTC7p by 1 mM IPTG-induction for 0, 1 and 2 h, respectively. Lane 4: Puri¢ed His-
vCaPTC7p (1 Wg). The gel was stained with Coommasie blue. Molecular mass (kDa) is indicated to the left of the gel. C: The e¡ects of the
cation cofactors Mg2 and Mn2 on the dephosphorylation activity of the recombinant His-vCaPTC7p. The concentrations of MgCl2 and
MnCl2 are indicated.
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(GenBank accession No.: CAB07860), the At5g66720 gene
product of Arabidopsis thaliana (GenBank accession No.:
NP_201473) and the azr1 protein of Schizosaccharomyces
pombe [5], respectively. The gene azr1 was originally isolated
as a multi-copy suppressor of the 5-azacytidine sensitivity of
G2 checkpoint and DNA repair-de¢cient S. pombe strains,
but the nature of the azr1 protein was unknown [5]. We ob-
served a potential PP2C catalytic domain in each of these
proteins from the four eukaryotic model organisms (data
not shown), indicating that the CaPTC7 phosphatase is highly
conserved in eukaryotes.
In summary, we describe the identi¢cation and character-
ization of the CaPTC7p, the ¢rst PP2C phosphatase in
C. albicans, encoded by the YHR76 gene. Our results suggest
that the CaPTC7p possesses the characteristics of classical
PP2C enzymes. The interesting structural features of
CaPTC7p and its high conservation in the eukaryotic organ-
isms make it a novel member of the PP2C superfamily.
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